Defining cancer risks for BRCA germline mutation carriers: implications for surgical prophylaxis

Editorial

Beth Y Karlan. Gynecol Oncol. 2004 Feb.

. 2004 Feb;92(2):519-20.

doi: 10.1016/j.ygyno.2003.12.009.

No abstract available

Comment on

Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?
Goshen R, Chu W, Elit L, Pal T, Hakimi J, Ackerman I, Fyles A, Mitchell M, Narod SA. Goshen R, et al. Gynecol Oncol. 2000 Dec;79(3):477-81. doi: 10.1006/gyno.2000.6003. Gynecol Oncol. 2000. PMID: 11104623
BRCA germline mutations in Jewish women with uterine serous papillary carcinoma.
Lavie O, Hornreich G, Ben-Arie A, Rennert G, Cohen Y, Keidar R, Sagi S, Lahad EL, Auslander R, Beller U. Lavie O, et al. Gynecol Oncol. 2004 Feb;92(2):521-4. doi: 10.1016/j.ygyno.2003.11.009. Gynecol Oncol. 2004. PMID: 14766242